Why did Tesla’s robotaxi attract federal regulators?
How will Iran's threats impact global oil prices?
Why is the US House banning WhatsApp on devices?
What caused Kroger to announce 60 store closures?
How did US strikes on Iran affect stock markets?
Why is the UK committing to 5% defense spending?
How is Goldman Sachs using generative AI firmwide?
Amgen’s obesity drug led to high discontinuation rates in mid-stage trial, as company plans to adjust dosing
statnews.com/2025/06/23/amgen-maritide-obesity-drug-trial-discontinuations-side-effects-dosing-changes
CHICAGO — Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a mid-stage trial, results that support the company’s decision to use a slower dosing schedule to make the drug more tolerable in further testing.
In the…
This story appeared on statnews.com, 2025-06-23 21:04:55.255000.